CorMedix (CRMD) News Today $8.84 -0.55 (-5.81%) As of 03:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Renaissance Technologies LLC Makes New $1.09 Million Investment in CorMedix Inc. (NASDAQ:CRMD)Renaissance Technologies LLC purchased a new stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 134,000 shares of the company'May 3 at 3:30 AM | marketbeat.comCorMedix (CRMD) Expected to Announce Earnings on TuesdayCorMedix (NASDAQ:CRMD) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-cormedix-inc-stock-1/)May 3 at 3:08 AM | marketbeat.comCorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025April 29, 2025 | globenewswire.comCorMedix Inc. (NASDAQ:CRMD) Receives $14.50 Consensus Price Target from AnalystsApril 29, 2025 | americanbankingnews.comCorMedix Inc. (NASDAQ:CRMD) Receives Average Rating of "Buy" from BrokeragesShares of CorMedix Inc. (NASDAQ:CRMD - Get Free Report) have received an average rating of "Buy" from the seven research firms that are currently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has issued a strong buApril 28, 2025 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Holdings Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. increased its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 40.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 273,218 shares of the company's stock after purchasing an addApril 26, 2025 | marketbeat.comGeode Capital Management LLC Acquires 108,356 Shares of CorMedix Inc. (NASDAQ:CRMD)Geode Capital Management LLC increased its holdings in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,392,820 shares of the company's stock after buyinApril 25, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Stock Price Up 4.7% - Should You Buy?CorMedix (NASDAQ:CRMD) Stock Price Up 4.7% - Here's What HappenedApril 23, 2025 | marketbeat.comAdvisory Services Network LLC Purchases New Shares in CorMedix Inc. (NASDAQ:CRMD)Advisory Services Network LLC acquired a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 51,600 shares of the company's stock, valued atApril 19, 2025 | marketbeat.comInvestors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five yearsApril 17, 2025 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. lifted its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 10.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,378,191 shares of the company's stock after acquiring an additional 309,514 shares during the period. VaApril 16, 2025 | marketbeat.comCorMedix's (CRMD) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $12.00 price objective on shares of CorMedix in a research note on Wednesday.April 11, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Given Buy Rating at D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $15.00 target price on shares of CorMedix in a research report on Tuesday.April 10, 2025 | marketbeat.comCorMedix reports preliminary Q1 revenue $39M, consensus $32.2M.April 9, 2025 | markets.businessinsider.comRBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-termApril 8, 2025 | markets.businessinsider.comCorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s ElatedApril 8, 2025 | msn.comCorMedix, Inc.: Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales GuidanceApril 8, 2025 | finanznachrichten.deCorMedix Shares Gain After 1Q Preliminary Sales Beat ViewsApril 8, 2025 | marketwatch.comCormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales GuidanceApril 8, 2025 | globenewswire.comRaymond James Financial Inc. Purchases New Holdings in CorMedix Inc. (NASDAQ:CRMD)Raymond James Financial Inc. acquired a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 115,661 shares of the company's stock, valued at approximately $937,April 6, 2025 | marketbeat.comRBC Capital Remains a Buy on Cormedix (CRMD)April 5, 2025 | markets.businessinsider.comCorMedix (NASDAQ:CRMD) Stock Rating Upgraded by StockNews.comStockNews.com upgraded shares of CorMedix from a "sell" rating to a "hold" rating in a research report on Tuesday.April 3, 2025 | marketbeat.comCorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 2, 2025 | globenewswire.comCorMedix Inc. (NASDAQ:CRMD) Receives Average Recommendation of "Buy" from BrokeragesCorMedix Inc. (NASDAQ:CRMD - Get Free Report) has received an average rating of "Buy" from the eight ratings firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. TheApril 2, 2025 | marketbeat.comQ1 Earnings Estimate for CorMedix Issued By Leerink PartnrsCorMedix Inc. (NASDAQ:CRMD - Free Report) - Investment analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for CorMedix in a report released on Tuesday, March 25th. Leerink Partnrs analyst R. Ruiz anticipates that the company will earn $0.23 per share for the quartMarch 29, 2025 | marketbeat.comCorMedix Inc. Reports Record Q4 Earnings and GrowthMarch 28, 2025 | tipranks.comCorMedix: A Fair-Priced Biotech Company With A Bright FutureMarch 28, 2025 | seekingalpha.comCORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the FirmMarch 27, 2025 | globenewswire.comCorMedix (NASDAQ:CRMD) Given "Outperform" Rating at Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and issued a $12.00 price objective on shares of CorMedix in a research report on Wednesday.March 27, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Given New $12.00 Price Target at Needham & Company LLCNeedham & Company LLC cut their price target on CorMedix from $18.00 to $12.00 and set a "buy" rating on the stock in a research note on Wednesday.March 27, 2025 | marketbeat.comThe Hidden Risks Behind CorMedix's First Profitable QuarterMarch 27, 2025 | seekingalpha.comCorMedix (NASDAQ:CRMD) Shares Gap Down - Here's What HappenedCorMedix (NASDAQ:CRMD) Shares Gap Down - Here's WhyMarch 26, 2025 | marketbeat.comTraders Buy Large Volume of Call Options on CorMedix (NASDAQ:CRMD)CorMedix Inc. (NASDAQ:CRMD - Get Free Report) saw unusually large options trading activity on Tuesday. Stock investors bought 4,076 call options on the company. This is an increase of approximately 170% compared to the average daily volume of 1,508 call options.March 26, 2025 | marketbeat.comCorMedix's (CRMD) Buy Rating Reaffirmed at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $15.00 price target on shares of CorMedix in a report on Tuesday.March 26, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Issues Earnings Results, Beats Estimates By $0.17 EPSCorMedix (NASDAQ:CRMD - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.17. The firm had revenue of $30.00 million for the quarter, compared to the consensus estimate of $27.46 million. CorMedix's quarterly revenue was up 29900.0% compared to the same quarter last year.March 26, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Posts Earnings Results, Beats Expectations By $0.17 EPSCorMedix (NASDAQ:CRMD - Get Free Report) released its earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.17. The business had revenue of $30.00 million during the quarter, compared to the consensus estimate of $27.46 million. The firm's quarterly revenue was up 29900.0% compared to the same quarter last year.March 26, 2025 | marketbeat.comCormedix Inc (CRMD) Q4 2024: Everything You Need To Know Ahead Of EarningsMarch 26, 2025 | finance.yahoo.comCorMedix Inc. Achieves Profitability with DefenCath LaunchMarch 26, 2025 | tipranks.comCorMedix Dives on ResultsMarch 25, 2025 | baystreet.caCorMedix Shares Plunge After 1H Guidance Missed ExpectationsMarch 25, 2025 | marketwatch.comCorMedix shares tumble after order delayMarch 25, 2025 | investing.comCorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It OffMarch 25, 2025 | msn.comCorMedix (CRMD) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | msn.comINVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLCMarch 25, 2025 | globenewswire.comCorMedix Inc. (CRMD) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | seekingalpha.comCorMedix Inc. Reports Q4 2024 Net Revenue of $31.2 Million and First Profitable Quarter in Company HistoryMarch 25, 2025 | quiverquant.comCorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 25, 2025 | globenewswire.comCorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallMarch 24, 2025 | benzinga.comCorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025March 18, 2025 | globenewswire.comTruist Financial Remains a Buy on Cormedix (CRMD)March 17, 2025 | markets.businessinsider.com Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.600.72▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼43▲CRMD Articles Average Week Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DNLI News IBRX News APLS News AAPG News BHVN News KYMR News CGON News MTSR News MIRM News BEAM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.